Paternity rates for men in their 30s increasing

Philadelphia--The birth rate for all U.S. men increased for fathers aged 30 to 39 years and decreased for fathers aged 20 to 29 years between 1993 and 2002. For fathers aged 40 and above, the rate remained stable, according to a new analysis of the federal National Vital Statistics Report.

Related Videos

Related Content

Advertisement

March 26th 2025

Bel-sar shows promising safety, efficacy in NMIBC

Hannah Clarke

In patients with intermediate-risk disease, 4 of 5 patients demonstrated a complete response.

March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS

Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.

March 25th 2025

FDA approves gepotidacin for uncomplicated UTI

Hannah Clarke

The approval is supported by data from the phase 3 EAGLE-2 and EAGLE-3 trials.

February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS

Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.

March 24th 2025

WATER III: Aquablation achieves comparable outcomes to laser enucleation for BPH

Hannah Clarke

The mean change in IPSS from baseline to 3 months was 12.9 in the Aquablation arm vs 13.1 in the LEP arm.

March 24th 2025

Additional NIAGARA data reinforce benefit of perioperative durvalumab in MIBC

Hannah Clarke

“The addition of the durvalumab did not make treatment more morbid than chemotherapy alone, and it didn't change or increase the surgical complications you saw in the ward," says James W.F. Catto, MBChB, PhD, FRCS.

Related Content

Advertisement

March 26th 2025

Bel-sar shows promising safety, efficacy in NMIBC

Hannah Clarke

In patients with intermediate-risk disease, 4 of 5 patients demonstrated a complete response.

March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS

Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.

March 25th 2025

FDA approves gepotidacin for uncomplicated UTI

Hannah Clarke

The approval is supported by data from the phase 3 EAGLE-2 and EAGLE-3 trials.

February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS

Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.

March 24th 2025

WATER III: Aquablation achieves comparable outcomes to laser enucleation for BPH

Hannah Clarke

The mean change in IPSS from baseline to 3 months was 12.9 in the Aquablation arm vs 13.1 in the LEP arm.

March 24th 2025

Additional NIAGARA data reinforce benefit of perioperative durvalumab in MIBC

Hannah Clarke

“The addition of the durvalumab did not make treatment more morbid than chemotherapy alone, and it didn't change or increase the surgical complications you saw in the ward," says James W.F. Catto, MBChB, PhD, FRCS.